Filing Flows

Filing Flows › Escalade (ESCA) › Recalls, complaints & regulation

Escalade (ESCA): recalls

Escalade (ESCA) beyond its filings: 0 recalls in the last 12 months (1 in five years, 0 Class I).

Latest recalls

Escalade's latest quarter

Escalade, Q3 2026: revenue $65.6M (-3% year over year), operating margin 13.2%, net earnings $6.7M, operating cash flow $14.9M. The chart follows the revenue to costs, profit and cash.

Questions

Has Escalade had any recalls?

1 recall on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.